CalciMedica, Inc.

CALC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $11.5M $7.9M $5.5M $1.3M $13.4M $33.4M $15.9M
Accounts Receivable — — — — — — —
Inventory — — — — — — —
Total Current Assets $13.5M $19.7M $11.6M $1.7M $67.1M $99.2M $36.3M
Property, Plant & Equipment $50.0K $119.0K $167.0K $147.0K $2.0M $1.9M $2.0M
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $13.6M $19.8M $12.2M $3.3M $69.1M $101.8M $40.7M
Liabilities
Accounts Payable $1.2M $2.0M $1.4M $2.9M $527.0K $2.5M $4.6M
Total Current Liabilities $3.8M $3.7M $4.0M $4.8M $4.1M $7.0M $12.3M
Long-Term Debt — — — — — — —
Total Liabilities $20.2M $5.4M $4.0M $12.6M $4.1M $7.0M $12.3M
Stockholders' Equity
Retained Earnings $-189.3M $-159.8M $-146.1M $-111.7M $-169.2M $-133.4M $-105.8M
Total Stockholders' Equity $-6.6M $14.4M $8.2M $-71.3M $-64.0M $94.8M $-103.0M